DR Horton Is Maintained at Overweight by Wells Fargo
D.R. Horton Analyst Ratings
Wells Fargo Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $175
Argus Adjusts Price Target on D.R. Horton to $190 From $200
Evercore Maintains D.R. Horton(DHI.US) With Buy Rating, Raises Target Price to $212
BofA Securities Maintains D.R. Horton(DHI.US) With Buy Rating, Announces Target Price $290
Oppenheimer Maintains D.R. Horton(DHI.US) With Hold Rating
D.R. Horton Analyst Ratings
Barclays Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $170
KBW Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $183
Seaport Global Maintains D.R. Horton(DHI.US) With Hold Rating
Seaport Global Maintains D.R. Horton(DHI.US) With Hold Rating
D.R. Horton Analyst Ratings
Raymond James Downgrades D.R. Horton(DHI.US) to Hold Rating
Erste Group Initiates D.R. Horton(DHI.US) With Hold Rating
J.P. Morgan Maintains D.R. Horton(DHI.US) With Hold Rating, Raises Target Price to $188
DR Horton Is Maintained at Neutral by JP Morgan
D.R. Horton Analyst Ratings
Barclays Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $192
KBW Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $200